المؤلفون: Mateo FJP; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. fpelegrin@santpau.cat., Guasch AD; Nephrology Department, Fundació Puigvert, Barcelona, Spain., Pineda JAG; Department of Pathology, Fundació Puigvert, Barcelona, Spain., Manrique ACV; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Cullell BM; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., López-Bravo DP; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Díaz JG; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Cascón AP; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Freiria XB; Nephrology Department, Fundació Puigvert, Barcelona, Spain.

المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Jun; Vol. 55 (2), pp. 965-968. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Springer Science+Business Media Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Capecitabine*/adverse effects , Thrombotic Microangiopathies*/chemically induced , Thrombotic Microangiopathies*/pathology , Thrombotic Microangiopathies*/diagnosis , Antimetabolites, Antineoplastic*/adverse effects, Humans ; Female ; Aged, 80 and over ; Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/pathology